Mannino, D.; Basilotta, R.; De Luca, F.; Casili, G.; Esposito, E.; Paterniti, I.
KRAS–SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC). Int. J. Mol. Sci. 2025, 26, 2579.
https://doi.org/10.3390/ijms26062579
AMA Style
Mannino D, Basilotta R, De Luca F, Casili G, Esposito E, Paterniti I.
KRAS–SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC). International Journal of Molecular Sciences. 2025; 26(6):2579.
https://doi.org/10.3390/ijms26062579
Chicago/Turabian Style
Mannino, Deborah, Rossella Basilotta, Fabiola De Luca, Giovanna Casili, Emanuela Esposito, and Irene Paterniti.
2025. "KRAS–SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC)" International Journal of Molecular Sciences 26, no. 6: 2579.
https://doi.org/10.3390/ijms26062579
APA Style
Mannino, D., Basilotta, R., De Luca, F., Casili, G., Esposito, E., & Paterniti, I.
(2025). KRAS–SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC). International Journal of Molecular Sciences, 26(6), 2579.
https://doi.org/10.3390/ijms26062579
